Document Detail


Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.
MedLine Citation:
PMID:  16352855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A characteristic finding of childhood HIV-associated hemolytic uremic syndrome (HIV-HUS) is the presence of endothelial injury and microcystic tubular dilation, leading to a rapid progression of the renal disease. We have previously shown that a secreted fibroblast growth factor-binding protein (FGF-BP) is upregulated in kidneys from children affected with HIV-HUS and HIV nephropathy. Here, we sought to determine the potential role of FGF-BP in the pathogenesis of HIV-HUS. By immunohistochemical and in situ hybridization studies, we observed FGF-BP protein and mRNA upregulation in regenerating renal tubular epithelial cells from kidneys of HIV-Tg26 mice with late-stage renal disease, that is, associated with the development of microcystic tubular dilatation and accumulation of FGF-2. Moreover, FGF-BP increased the FGF-2-dependent growth and survival of cultured primary human renal glomerular endothelial cells and enhanced FGF-2-induced MAPK/ERK2 activation, as well as the proliferation of immortalized GM7373 endothelial cells. We propose that HIV-Tg26 mice are a clinically relevant model system to study the role of FGF-BP in the pathogenesis of HIV-associated renal diseases. Furthermore, the upregulation of FGF-BP by regenerating renal tubular epithelial cells may provide a mechanism by which the regenerative and angiogenic activity of FGF-2 in renal capillaries can be modulated in children with HIV-HUS and other renal disease.
Authors:
Patricio E Ray; Elena Tassi; Xue-Hui Liu; Anton Wellstein
Related Documents :
16283245 - Contraindications can damage your health--is metformin a case in point?
15518775 - Microscopic examination of the urine helps to confirm the recovery of acute tubular nec...
1308855 - Pathological release of urinary endopeptidase 24.11 early after renal transplantation.
16112595 - Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
3293335 - Changes in heparin level in experimental liver transplantation in dog.
9697675 - Pharmacokinetics of mycophenolic acid (mpa) and determinants of mpa free fraction in pe...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of physiology. Regulatory, integrative and comparative physiology     Volume:  290     ISSN:  0363-6119     ISO Abbreviation:  Am. J. Physiol. Regul. Integr. Comp. Physiol.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-14     Completed Date:  2006-02-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100901230     Medline TA:  Am J Physiol Regul Integr Comp Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  R105-13     Citation Subset:  IM    
Affiliation:
Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Rd., Washington DC 20057, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carrier Proteins / genetics,  metabolism*
Cell Line
Endothelial Cells / metabolism
Fibroblast Growth Factor 2 / metabolism
HIV Infections / complications*,  metabolism
Hemolytic-Uremic Syndrome / complications*,  metabolism*,  physiopathology
Heparitin Sulfate / metabolism
Humans
Kidney / cytology,  metabolism
Mice
Mice, Transgenic
Up-Regulation
Grant Support
ID/Acronym/Agency:
HL-55605/HL/NHLBI NIH HHS; R-01-CA71508/CA/NCI NIH HHS; R-01-DK-49419/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Carrier Proteins; 0/Fgfbp1 protein, mouse; 103107-01-3/Fibroblast Growth Factor 2; 139946-12-6/FGFBP1 protein, human; 9050-30-0/Heparitin Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fetal programming of hypertension.
Next Document:  Physiological and pathophysiological aspects of ceramide.